Back

miRNA-29-CLIP uncovers new targets and functions to improve skin repair

Thiagarajan, L.; Sanchez-Alvarez, R.; Kambara, C.; Rajasekar, P.; Wang, Y.; Halloy, F.; Hall, J.; Stark, H.-J.; Martin, I.; Boukamp, P.; Kurinna, S.

2024-05-02 cell biology
10.1101/2024.05.02.591622 bioRxiv
Show abstract

MicroRNAs (miRNAs) control organogenesis in mammals but their role in specific cell types is not fully explored. miRNAs exert their function by binding mRNAs and inhibiting translation. Skin is an excellent model to study the role of miRNAs in primary cells of epidermal (keratinocytes) and mesodermal (fibroblasts) origin, because the growth of these cells is tightly controlled at translation. Previous research demonstrated that miRNA-29 family functions during skin repair, however, the exact mRNA targets and the downstream mechanisms of miRNA-29-mediated regulation of cell growth is missing. Here, we use miRNA crosslinking and immunoprecipitation (miRNA-CLIP) method to find the direct targets of miRNA-29 in keratinocytes and fibroblasts from human skin. We uncover previously unrecognized roles of miRNA-29 in protein folding and RNA processing, common to all cell types tested, and determine the cell-specific role of miRNA-29. Using modified anti-sense oligonucleotides (ASO) in 2D and 3D cultures of keratinocytes and fibroblasts, we enhanced cell-to-matrix adhesion and found an autocrine and paracrine mechanism of miRNA-29-dependent cell growth. Our results include a comprehensive list and functional analyses of mRNAs directly bound by miRNA-29 keratinocytes and fibroblasts, determined by miRNA-CLIP and ASO-mediated inhibition of miRNA-29 followed by RNA-seq. We reveal a full transcriptome of human keratinocytes with enhanced adhesion to the wound matrix, which supports regeneration of the epidermis and is regulated by miRNA-29. The functions of miRNA-29 identified in this study can provide a new approach to improve cutaneous repair by restoring and enhancing the endogenous mechanisms through the stage-specific delivery of miRNA-29 ASO.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
iScience
1063 papers in training set
Top 0.5%
8.5%
2
Genomics, Proteomics & Bioinformatics
171 papers in training set
Top 0.7%
8.5%
3
eLife
5422 papers in training set
Top 13%
6.4%
4
Journal of Molecular Cell Biology
21 papers in training set
Top 0.1%
6.4%
5
Cell Discovery
54 papers in training set
Top 0.9%
4.9%
6
Protein & Cell
25 papers in training set
Top 0.3%
4.9%
7
Cell Reports
1338 papers in training set
Top 9%
4.9%
8
Scientific Reports
3102 papers in training set
Top 27%
4.4%
9
Developmental Cell
168 papers in training set
Top 4%
4.4%
50% of probability mass above
10
Nucleic Acids Research
1128 papers in training set
Top 5%
3.7%
11
Journal of Investigative Dermatology
42 papers in training set
Top 0.2%
3.7%
12
Journal of Genetics and Genomics
36 papers in training set
Top 0.6%
2.4%
13
Nature Communications
4913 papers in training set
Top 48%
1.9%
14
PLOS ONE
4510 papers in training set
Top 53%
1.7%
15
Advanced Science
249 papers in training set
Top 10%
1.7%
16
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 4%
1.7%
17
Cell Proliferation
12 papers in training set
Top 0.2%
1.5%
18
The FASEB Journal
175 papers in training set
Top 2%
1.2%
19
Clinical and Translational Medicine
30 papers in training set
Top 0.5%
1.2%
20
Cells
232 papers in training set
Top 5%
0.9%
21
International Journal of Molecular Sciences
453 papers in training set
Top 13%
0.9%
22
Frontiers in Genetics
197 papers in training set
Top 9%
0.8%
23
Cell Reports Methods
141 papers in training set
Top 5%
0.8%
24
Cell Death & Disease
126 papers in training set
Top 3%
0.7%
25
Stem Cells
28 papers in training set
Top 0.5%
0.7%
26
Science Advances
1098 papers in training set
Top 31%
0.7%
27
Acta Biochimica et Biophysica Sinica
19 papers in training set
Top 1%
0.7%
28
PLOS Genetics
756 papers in training set
Top 17%
0.7%
29
Molecular Therapy
71 papers in training set
Top 4%
0.5%
30
Theranostics
33 papers in training set
Top 2%
0.5%